Nocodazole

Catalog No.S2775 Batch:S277502

Print

Technical Data

Formula

C14H11N3O3S
Molecular Weight 301.32 CAS No. 31430-18-9
Solubility (25°C)* In vitro DMSO 7.5 mg/mL (24.89 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
0.38mg/ml Taking the 1 mL working solution as an example, add 50 μL 7.5 mg/ml clarified DMSO stock solution to 400 μL PEG300, mix evenly to clarify it; add 50 μL Tween80 to the above system, mix evenly to clarify it; then continue to add 500 μL ddH2O to make it clear. Volume up to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Nocodazole is a rapidly-reversible inhibitor of microtubule polymerization, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 of 0.21 μM, 0.53 μM and 0.64 μM in cell-free assays, respectively. Nocodazole induces apoptosis.
Targets
Microtubules [2]
(Cell-free assay)		 Abl [1]
(Cell-free assay)		 Abl (E255K) [1]
(Cell-free assay)		 Abl (T315I) [1]
(Cell-free assay)
0.21 μM 0.53 μM 0.64 μM
In vitro

Nocodazole is a high-affinity ligand for the cancer-related kinases including Abl phosphorylated, c-Kit, BRAF, and MEK with Kd of 0.091 μM, 1.6 μM, 1.8 μM and 1.6 μM, respectively. In addition, the Kd of Nocodazole for Abl(E255K) phosphorylated, Abl(T315I) phosphorylated, BRAF(V600E) and PI3Kγ is 0.12 μM, 0.17 μM, 1.1 μM and 1.5 μM, respectively. Nocodazole induces apoptosis in chronic lymphocytic leukemia cells. Nocodazole inhibits insulin-stimulated glucose transport. Nocodazole decreases apoptosis in some human colon carcinoma cells. Nocodazole impairs the morphology and directionality of migrating medial gan-glionic eminence cells. [1]

At high concentrations, Nocodazole rapidly depolymerizes microtubules in cells, while low concentrations of Nocodazole inhibit microtubule dynamic instability. [2]

Mitotic cells incubated with different concentrations are inhibited from progressing to G1 phase 6 hours after release from the Nocodazole block, with a median inhibitory concentration of 4 nM. Nocodazole-pretreated cells exposed in the absence of Nocodazole only form free-floating microtubules, whereas pretreated cells exposed in the presence of Nocodazole-assembled centrosome organize microtubules. [3]

Nocodazole disrupts microtubules by binding to β-tubulin. Nocodazole prevents the formation of one of the two interchain disulfide linkages. Nocodazole impairs the transport of vesicles. Nocodazole suppress METH-induced cell death and lysosomal dysfunction. METH-induced cell death is significantly decreased by Nocodazole pretreatment in comparison to METH alone. [4]

Nocodazole doubles HDR efficiency to up to 30% in iPSCs. It improves the CRISPR-mediated HDR efficiency and has an additive effect on enhancing precise genome editing[6].
In vivo

The tumor volume and tumor weight of the mice treated with Nocodazole are significantly reduced as compared with those treated with Nocodazole alone. Combined treatment with Nocodazole strongly enhances apoptosis of COLO 205 tumor xenografts treated with Nocodazole alone. [5]

Protocol (from reference)

Cell Assay:

[7]
  • Cell lines

    H1975 cells

  • Concentrations

    50 ng/ml

  • Incubation Time

    24 h

  • Method

    Cells were treated with indicated concentration of the drug for 24 hour.
Animal Study:

[5]
  • Animal Models

    Nude mice with COLO-205 tumor xenografts

  • Dosages

    5 mg/kg

  • Administration

    Administered via i.p.

Customer Product Validation

, , J Biol Chem, 2016, 291:14761-14772.

Data from [Data independently produced by , , Cancer Res, 2018, doi:10.1158/0008-5472.CAN-18-0520]

Data from [Data independently produced by , , Cell Signal, 2016, 28(12):1826-1832]

Data from [Data independently produced by , , J Biol Chem, 2017, 292(19):7806-7816]

Selleck's Nocodazole has been cited by 120 publications

mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer [ Nat Cell Biol, 2024, 10.1038/s41556-024-01473-0] PubMed: 39080411
A noncoding variant confers pancreatic differentiation defect and contributes to diabetes susceptibility by recruiting RXRA [ Nat Commun, 2024, 15(1):9771] PubMed: 39532884
BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A [ Nucleic Acids Res, 2024, gkae605] PubMed: 38989615
A non-canonical role of the inner kinetochore in regulating sister-chromatid cohesion at centromeres [ EMBO J, 2024, 10.1038/s44318-024-00104-6] PubMed: 38714893
Cep57 regulates human centrosomes through multivalent interactions [ Proc Natl Acad Sci U S A, 2024, 121(25):e2305260121] PubMed: 38857398
Mechanical stress-induced autophagy is cytoskeleton dependent [ Cell Prolif, 2024, e13728.] PubMed: 39155403
Acidic preconditioning induced intracellular acid adaptation to protect renal injury via dynamic phosphorylation of focal adhesion kinase-dependent activation of sodium hydrogen exchanger 1 [ Cell Commun Signal, 2024, 22(1):393.] PubMed: 39118129
KIF22 regulates mitosis and proliferation of chondrocyte cells [ iScience, 2024, 27(7):110151] PubMed: 38989461
Nucleolar protein TAAP1/C22orf46 confers pro-survival signaling in non-small cell lung cancer [ Life Sci Alliance, 2024, 7(4)e202302257] PubMed: 38228372
Endothelial cell elongation and alignment in response to shear stress requires acetylation of microtubules [ Front Physiol, 2024, 15:1425620] PubMed: 39318362

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.